News

Cell TherapiesR&D project spotlight: A collaborative approach to developing a universal ddPCR™ assay to detect residual pluripotent stem cells in cell therapy products
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2026202520242023 →
Press release: Annual Review 2019 highlights impact of CGT Catapult in accelerating the delivery of advanced therapies to patientsPress release: Annual Review 2019 highlights impact of CGT Catapult in accelerating the delivery of advanced therapies to patientsRegulatory news - June 2019Regulatory news - June 2019May news: Accelerating patient access to advance therapiesMay news: Accelerating patient access to advance therapiesRegulatory news - May 2019Regulatory news - May 2019April news: Spotlight on manufacturingApril news: Spotlight on manufacturingPress release: CGT Catapult to target a barrier to the rapid expansion of the industry, by developing analytics for high throughput quality controlPress release: CGT Catapult to target a barrier to the rapid expansion of the industry, by developing analytics for high throughput quality controlNobel Prize-winning stem cell researcher, Professor Shinya Yamanaka, visits CGT CatapultNobel Prize-winning stem cell researcher, Professor Shinya Yamanaka, visits CGT CatapultRegulatory news - April 2019Regulatory news - April 2019Celebrating one year of operation at the Cell and Gene Therapy Catapult manufacturing centreCelebrating one year of operation at the Cell and Gene Therapy Catapult manufacturing centreBringing SMEs together with investors to secure funding for the UK industryBringing SMEs together with investors to secure funding for the UK industryiMATCH ATTC given boost for expanding use of cell and gene therapies in the UKiMATCH ATTC given boost for expanding use of cell and gene therapies in the UKRegulatory news - March 2019Regulatory news - March 2019